相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Standard CD44 modulates YAP1 through a positive feedback loop in hepatocellular carcinoma
Zhenhai Fan et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
miR-302/367/LATS2/YAP pathway is essential for prostate tumor- propagating cells and promotes the development of castration resistance
Y. Guo et al.
ONCOGENE (2017)
Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis
Kosuke Tanaka et al.
CANCER LETTERS (2017)
CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling
Jen-Chih Tseng et al.
ONCOTARGET (2016)
The Hippo Pathway Effector YAP Regulates Motility, Invasion, and Castration-Resistant Growth of Prostate Cancer Cells
Lin Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression
Shiyi Yu et al.
ONCOTARGET (2015)
EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1)
Tzyh-Chyuan Hour et al.
ARCHIVES OF TOXICOLOGY (2015)
CD44 acts through RhoA to regulate YAP signaling
Yuchen Zhang et al.
CELLULAR SIGNALLING (2014)
Isolation and characterization of calcium sensing receptor null cells: A highly malignant and drug resistant phenotype of colon cancer
Navneet Singh et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Drug-resistant breast cancer cell line displays cancer stem cell phenotype and responds sensitively to epigenetic drug SAHA
Shan Lu et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2013)
An Immunohistochemical Signature Comprising PTEN, MYC, and Ki67 Predicts Progression in Prostate Cancer Patients Receiving Adjuvant Docetaxel After Prostatectomy
Emmanuel S. Antonarakis et al.
CANCER (2012)
In Vitro and In Vivo Prostate Cancer Metastasis and Chemoresistance Can Be Modulated by Expression of either CD44 or CD147
Jingli Hao et al.
PLOS ONE (2012)
CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression
Rhonda L. Brown et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin
Haiying Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
Chih-Pin Chuu et al.
JOURNAL OF BIOMEDICAL SCIENCE (2011)
Class III β-Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy
Guillaume Ploussard et al.
CANCER RESEARCH (2010)
CD44 Attenuates Activation of the Hippo Signaling Pathway and Is a Prime Therapeutic Target for Glioblastoma
Yin Xu et al.
CANCER RESEARCH (2010)
Systems analysis of EGF receptor signaling dynamics with microwestern arrays
Mark F. Ciaccio et al.
NATURE METHODS (2010)
The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations
Anna Dubrovska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
CD44+CD24- prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
E. M. Hurt et al.
BRITISH JOURNAL OF CANCER (2008)
The emerging role of the Hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals
Qi Zeng et al.
CANCER CELL (2008)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells
Lilly Y. W. Bourguignon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Prostate cancer stem cells: A new target for therapy
Norman J. Maitland et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Involvement of CD44, a molecule with a thousand faces, in cancer dissemination
David Naor et al.
SEMINARS IN CANCER BIOLOGY (2008)
Tumor suppressor LATS1 is a negative regulator of oncogene YAP
Yawei Hao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Hierarchical organization of prostate cancer cells in xenograft tumors:: The CD44+α2β1+ cell population is enriched in tumor-initiating cells
Lubna Patrawala et al.
CANCER RESEARCH (2007)
The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network
Kieran Harvey et al.
NATURE REVIEWS CANCER (2007)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
IF Tannock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
CD44: From adhesion molecules to signalling regulators
H Ponta et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
The current state of hormonal therapy for prostate cancer
BA Hellerstedt et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2002)
分享论文
